Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

About the Cover

November 07, 2016; Volume 11,Issue 11

Cover image

Cover image expansion

On the Cover

A 32-year-old woman with end-stage renal disease of unknown etiology underwent deceased donor renal transplantation. She was given induction with basiliximab and was on tacrolimus, mycophenolate mofetil and prednisolone. She was discharged with a creatinine of 1.7 mg/dl. She developed new-onset diabetes after transplantation controlled with insulin. Three months later she developed fever, abdominal pain, graft tenderness and worsening renal function. Lab investigations revealed Hb7.1gm/dl, white blood cell count 17900/ mcL, and creatinine 4.0mg/dl. Liver function tests, serum amylase and lipase were normal. Blood cultures were negative and she was placed on broad spectrum antibiotics. Doppler flow imaging of the graft kidney showed absent arterial flow and a nephrectomy was performed. Histology revealed extensive coagulative necrosis of the kidney which was infiltrated by aseptate broad fungal hyphae with irregular, non-parallel contours which branched irregularly at right angles. The fungus invaded blood vessel walls, consistent with mucormycosis. Following the nephrectomy, this patient received liposomal Amphotericin B but she expired 3 weeks later due to overwhelming sepsis. Mucormycosis is a systemic fungal infection caused by members of the class Zygomycetes. The infection occurs mostly in immunocompromised individuals. The organism gains entry through inhalation, ingestion, contamination of skin wounds or via vascular channels such as intravenous drips. They are angioinvasive and can cause vascular thrombosis, tissue infarction and necrosis. There are 5 forms of the disease: rhinocerebral, pulmonary, gastrointestinal tract, cutaneous and disseminated disease. Renal mucormycosis, which is usually a part of disseminated disease, is a rare complication of kidney transplantation with a high mortality rate. Diagnos is is usually made by demonstration of characteristic fungal hyphae in the infectedt issue on histopathological examination. The treatment is based on early recognition of the disease, surgical resection of necrotict issue and appropriate antifungaltherapy. (Cover image and text provided by Anila Kurien and Ramanathan Vijayakumar, Center for Renal and Urological Pathology, Chennai, Tamil Nadu, India.)

Back to top
PreviousNext

In this issue

Clinical Journal of the American Society of Nephrology: 11 (11)
Clinical Journal of the American Society of Nephrology
Vol. 11, Issue 11
November 07, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
View Selected Citations (0)

Jump to

  • Editorials
  • Original Articles
    • Acute Kidney Injury
    • Chronic Kidney Disease
    • Diabetes and the kidney
    • Epidemiology and Outcomes
    • ESRD and Chronic Dialysis
    • Geriatric Nephrology
    • Health Services Research
    • Mineral Metabolism/Bone Disease
    • Renal Transplantation
  • Erratum
  • Glomerular Diseases: Update for the Clinician
  • Evidence-Based Nephrology
  • Commentary
  • Controversies in Nephrology
  • Commentaries
  • Most Read
Loading
  • Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration
  • Mitigating Risk of COVID-19 in Dialysis Facilities
  • COVID-19 and the Inpatient Dialysis Unit
  • COVID-19 in Patients with Kidney Disease
  • Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
More...

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire